Cardiomyopathy risk factors: Difference between revisions
Lina Yaqoub (talk | contribs) No edit summary |
No edit summary |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Cardiomyopathy}} | {{Cardiomyopathy}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{EdzelCo}} | ||
==Overview== | ==Overview== | ||
Some of the risk factors for developing cardiomyopathy include; a family history of cardiomyopathy, [[heart failure]], or [[sudden death]], a history of other diseases that may lead to cardiomyopathy, [[obesity]], [[alcoholism]], and long standing [[high blood pressure]]. Certain diseases such as [[hemachromotosis]], [[amyloidosis]], and [[sarcoidosis]] also increase the risk of developing cardiomyopathy. | Some of the risk factors for developing cardiomyopathy include; a family history of cardiomyopathy, [[heart failure]], or [[sudden death]], a history of other diseases that may lead to cardiomyopathy, [[obesity]], [[alcoholism]], and long standing [[high blood pressure]]. Certain diseases such as [[hemachromotosis]], [[amyloidosis]], and [[sarcoidosis]] also increase the risk of developing cardiomyopathy. | ||
==Risk Factors== | ==Risk Factors== | ||
Certain diseases, conditions, or factors can raise the risk for cardiomyopathy. Major risk factors include: | Certain diseases, conditions, or factors can raise the risk for cardiomyopathy. Major risk factors include:<ref name="pmid20141097">{{cite journal |vauthors=Wexler RK, Elton T, Pleister A, Feldman D |title=Cardiomyopathy: an overview |journal=Am Fam Physician |volume=79 |issue=9 |pages=778–84 |date=May 2009 |pmid=20141097 |doi= |url=}}</ref><ref name="pmid24976920">{{cite journal |vauthors=Sisakian H |title=Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies |journal=World J Cardiol |volume=6 |issue=6 |pages=478–94 |date=June 2014 |pmid=24976920 |doi=10.4330/wjc.v6.i6.478 |url=}}</ref> | ||
* A family history of cardiomyopathy, [[heart failure]], or [[sudden cardiac arrest]] (SCA) | * A family history of cardiomyopathy, [[heart failure]], or [[sudden cardiac arrest]] (SCA) | ||
| Line 16: | Line 17: | ||
==References== | ==References== | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
| Line 24: | Line 24: | ||
[[Category:Up-To-Date cardiology]] | [[Category:Up-To-Date cardiology]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Latest revision as of 03:33, 27 October 2023
|
Cardiomyopathy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Guidelines |
|
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy |
|
Case Studies |
|
Cardiomyopathy risk factors On the Web |
|
American Roentgen Ray Society Images of Cardiomyopathy risk factors |
|
Risk calculators and risk factors for Cardiomyopathy risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, DMD, MD[2]
Overview
Some of the risk factors for developing cardiomyopathy include; a family history of cardiomyopathy, heart failure, or sudden death, a history of other diseases that may lead to cardiomyopathy, obesity, alcoholism, and long standing high blood pressure. Certain diseases such as hemachromotosis, amyloidosis, and sarcoidosis also increase the risk of developing cardiomyopathy.
Risk Factors
Certain diseases, conditions, or factors can raise the risk for cardiomyopathy. Major risk factors include:[1][2]
- A family history of cardiomyopathy, heart failure, or sudden cardiac arrest (SCA)
- A disease or condition that can lead to cardiomyopathy, such as coronary heart disease, heart attack, or a viral infection that inflames the heart muscle
- Diabetes or other metabolic diseases, or severe obesity
- Diseases that can damage the heart, such as hemochromatosis, sarcoidosis, or amyloidosis
- Long-term alcoholism
- Long-term high blood pressure
References
- ↑ Wexler RK, Elton T, Pleister A, Feldman D (May 2009). "Cardiomyopathy: an overview". Am Fam Physician. 79 (9): 778–84. PMID 20141097.
- ↑ Sisakian H (June 2014). "Cardiomyopathies: Evolution of pathogenesis concepts and potential for new therapies". World J Cardiol. 6 (6): 478–94. doi:10.4330/wjc.v6.i6.478. PMID 24976920.